<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00807924</url>
  </required_header>
  <id_info>
    <org_study_id>BR001</org_study_id>
    <nct_id>NCT00807924</nct_id>
  </id_info>
  <brief_title>American Breast Laser Ablation Therapy Evaluation</brief_title>
  <acronym>ABLATE</acronym>
  <official_title>American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novian Health Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novian Health Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this patient tracking program is to monitor long term safety and effectiveness
      of the Novilase™ device and method in real world application.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABLATE is a prospective, observational multi-center tracking database which will evaluate
      clinical outcomes from patients undergoing Novilase for benign breast conditions (i.e.
      fibroadenomas, papillomas, etc). Data captured will assess the potential advantages and
      disadvantages of the procedure as compared with lumpectomy. Tumor characteristics, equipment
      used, complications, patient satisfaction and cosmesis ratings will also be tracked.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To monitor and measure long term safety and effectiveness Novilase</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To help refine, improve and/or validate breast tumor best practices and standard of care</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To help establish uniform and standardized imaging, pathological assessment and ablation timing protocols</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To support the medical and patient communities through transparency--by contributing and publishing relevant, useful and meaningful data to support the development and design of future research</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Benign Breast Conditions; Breast Fibroadenomas</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing Novilase for the treatment of benign breast conditions at Novian Health
        affiliated breast centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis confirmed by needle core biopsy

          -  Tumors detected either by physical exam or imaging

          -  Tumors do not exceed 2 cm in diameter and measure at least 0.5 cm away from the skin
             and chest wall

          -  Single, multiple and/or bilateral tumors

          -  Patient has given consent prior to being treated with Novilase™

        Exclusion Criteria:

          -  Patient is pregnant or lactating

          -  Hypercellularity suggestive of phyllodes

          -  Atypia

          -  Equivocal pathology report (e.g., discordance between radiographic and microscopic
             results)

          -  Fibroadenomas with stromal solidarity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Schwartzberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rose Medical Center - Rose Breast Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marti DeLay</last_name>
    <phone>312-266-7200</phone>
    <email>info@novianhealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eugene Bajorinas</last_name>
    <phone>312-266-7200</phone>
    <email>info@novianhealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Breast Center of Southern Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Whitacre, M.D.</last_name>
      <phone>520-319-6686</phone>
    </contact>
    <investigator>
      <last_name>Eric Whitacre, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rose Medical Center - Rose Breast Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Schwartzberg, M.D.</last_name>
      <phone>303-320-7127</phone>
      <email>info@novianhealth.com</email>
    </contact>
    <investigator>
      <last_name>Barbara Schwartzberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center - Department of Surgery</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Chen, M.D.</last_name>
      <phone>212-305-9676</phone>
    </contact>
    <investigator>
      <last_name>Margaret Chen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sheldon Feldman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bret Taback, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Preya Ananthakrishnan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.novianhealth.com</url>
    <description>Sponsor website</description>
  </link>
  <reference>
    <citation>Dowlatshahi K, Francescatti DS, Bloom KJ. Laser therapy for small breast cancers. Am J Surg. 2002 Oct;184(4):359-63.</citation>
    <PMID>12383903</PMID>
  </reference>
  <reference>
    <citation>Dowlatshahi K, Dieschbourg JJ, Bloom KJ. Laser therapy of breast cancer with 3-year follow-up. Breast J. 2004 May-Jun;10(3):240-3.</citation>
    <PMID>15125752</PMID>
  </reference>
  <reference>
    <citation>Dowlatshahi K, Wadhwani S, Alvarado R, Valadez C, Dieschbourg J. Interstitial laser therapy of breast fibroadenomas with 6 and 8 year follow-up. Breast J. 2010 Jan-Feb;16(1):73-6. doi: 10.1111/j.1524-4741.2009.00830.x. Epub 2009 Oct 12.</citation>
    <PMID>19825000</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2008</study_first_submitted>
  <study_first_submitted_qc>December 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2008</study_first_posted>
  <last_update_submitted>March 30, 2017</last_update_submitted>
  <last_update_submitted_qc>March 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibroadenomas</keyword>
  <keyword>Papillomas</keyword>
  <keyword>Breast</keyword>
  <keyword>Minimally invasive</keyword>
  <keyword>Interstitial laser therapy</keyword>
  <keyword>Laser ablation</keyword>
  <keyword>Benign</keyword>
  <keyword>Non-cancerous</keyword>
  <keyword>Breast lesion</keyword>
  <keyword>Breast tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibroadenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

